Vimarsana
Biggest News Aggregation in the World

Michael Kamarck News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Michael Kamarck. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Michael Kamarck Today - Breaking & Trending Today

Passage Bio, Inc. (PASG) CEO Edgar Cale on Q2 2022 Results - Earnings Call Transcript - Vimarsana News

Passage Bio, Inc. (PASG) CEO Edgar Cale on Q2 2022 Results - Earnings Call Transcript

Published: August 6, 2022

Passage Bio, Inc. (NASDAQ:NASDAQ:PASG) Q2 2022 Earnings Conference Call August 04, 2022, 08:30 AM ET Company Participants Stuart Henderson - VP of Corporate Development and IR Edgar Cale -...

Source: seekingalpha.com
Related Topics:
United StatesNew JerseyUnited KingdomLaura ChicoNeena Bitritto GargSimona KingRaymond JamesAlex NackenoffMark FormanBrendan SmithEdgar CaleMichael KamarckStuart HendersonCompany ParticipantsCorporate DevelopmentPassage Bio IncUpenn Gene Therapy ProgramGene Therapy ProgramPassage BioConference Call AugustPassage Bio Second QuarterOperating Results ConferenceVice PresidentPress ReleasesChip Cale
Vaxcyte Appoints Carlos Paya and Michael Kamarck to Its - Vimarsana News

Vaxcyte Appoints Carlos Paya and Michael Kamarck to Its

Published: October 28, 2021

FOSTER CITY, Calif., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve global health...

Source: globenewswire.com
Related Topics:
Carlos PayaMerck BioventuresJanet GraesserMichael KamarckAndrew GuggenhimeEli LillyVir Biotechnology IncGroupa StrepComplutense University Of MadridVice Dean For The Clinical Investigation ProgramSanofi Biotech Advisory CouncilMayo Medical SchoolBayer AgWyeth Management TeamElan PharmaceuticalsWyeth PharmaceuticalsMassachusetts Institute Of TechnologyDesign CorpOberlin CollegeExchange CommissionSutro Biopharma IncCorporate CommunicationsBiogen IdecVaxcyte IncInterim Chair